Literature DB >> 9372972

Urea kinetic modeling for CRRT.

L Garred1, M Leblanc, B Canaud.   

Abstract

Urea kinetic modeling (UKM) for dialysis quantification and prescription, although widely used in chronic renal failure (CRF), has been largely absent in the acute setting. A quantitative approach to prescription of continuous renal replacement therapies (CRRTs) for acute renal failure (ARF) based on UKM is presented. For patients with a relatively constant urea generation rate, G, who are receiving a fixed dose of CRRT, blood urea nitrogen (BUN) falls in an exponential fashion, approaching a plateau level after 3 to 4 days of continuous treatment. The CRRT clearance, K, necessary to achieve a desired plateau value of BUN, Cgoal, may be computed as G/Cgoal x K for all but predilutional CRRT modalities may be calculated as equal to the effluent (dialysate plus ultrafiltrate) flow rate from the filter. Urea mass balance equations are proposed for the determination of patient G value either during the pretreatment rise in BUN or during the decline in BUN with CRRT. In the absence of a reliable estimate of patient G, a reasonable CRRT starting prescription is to set the filter effluent rate in liters per hour (approximately K) to 1.2 times the patient's body weight in kilograms divided by the desired Cgoal in milligrams per deciliter. This relationship assumes moderate hypercatabolism (normalized protein catabolic rate = 2.0 g/kg/d) and patient urea distribution volume equal to 60% of body weight. For Cgoal = 60 mg/dL, this reduces to an easily remembered formula for K (in L/hr) of twice the patient's body weight divided by 100.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372972     DOI: 10.1016/s0272-6386(97)90535-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

Review 1.  Dosing of renal replacement therapy in acute kidney injury.

Authors:  Anitha Vijayan; Paul M Palevsky
Journal:  Am J Kidney Dis       Date:  2012-01-11       Impact factor: 8.860

Review 2.  Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury.

Authors:  Sean M Bagshaw; Michael Darmon; Marlies Ostermann; Fredric O Finkelstein; Ron Wald; Ashita J Tolwani; Stuart L Goldstein; David J Gattas; Shigehiko Uchino; Eric A Hoste; Stephane Gaudry
Journal:  Intensive Care Med       Date:  2017-03-13       Impact factor: 17.440

3.  Toward the optimal dose metric in continuous renal replacement therapy.

Authors:  Rolando Claure-Del Granado; Etienne Macedo; Glenn M Chertow; Sharon Soroko; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Ravindra L Mehta
Journal:  Int J Artif Organs       Date:  2012-06       Impact factor: 1.595

Review 4.  Nomenclature for renal replacement therapy in acute kidney injury: basic principles.

Authors:  Mauro Neri; Gianluca Villa; Francesco Garzotto; Sean Bagshaw; Rinaldo Bellomo; Jorge Cerda; Fiorenza Ferrari; Silvia Guggia; Michael Joannidis; John Kellum; Jeong Chul Kim; Ravindra L Mehta; Zaccaria Ricci; Alberto Trevisani; Silvio Marafon; William R Clark; Jean-Louis Vincent; Claudio Ronco
Journal:  Crit Care       Date:  2016-10-10       Impact factor: 9.097

Review 5.  Methods for dose quantification in continuous renal replacement therapy: Toward a more precise approach.

Authors:  Gianluca Villa; Sergio Fabbri; Sara Samoni; Matteo Cecchi; Antonio Fioccola; Caterina Scirè-Calabrisotto; Gaia Mari; Diego Pomarè Montin; Stefano Romagnoli
Journal:  Artif Organs       Date:  2021-08-18       Impact factor: 3.094

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.